IPO
Autolus Therapeutics
We are a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer
Symbol
AUTL
Price Range
$15.00 - $17.00
Anticipated Date
TBD
Underwriters
Goldman Sachs & Co. LLC, Jefferies, Wells Fargo Securities, William Blair
To view the prospectus for Autolus Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277